4 European Projects Found
Searched on 125080 European Projects
FINISHED
Host and viral factors in acute hepatitis C (HEPACUTE)
Start date: Nov 1, 2010, End date: Apr 30, 2014,
...epatitis C in their respective regions, and contributed considerably to our understanding of mechanisms of spontaneous viral clearance. The HepaCute proposal is closely connected to ongoing national, European, and Egyptian networks on HCV research (HepNet, EASL, STDF), which will support HepaCute to make it a success.Together with another pertinent EU-funded research project, SPHINX, it actively c ...
Read Project
17
Partners Participants
FINISHED
"Health and the Understanding of Metabolism, Aging and Nutrition" (HUMAN)
Start date: Oct 1, 2013, End date: Sep 30, 2018,
...e complex molecular mechanisms and circuitry across organs (e.g. hypothalamus-liver axis) which lead to pathology. HUMAN associates a core of outstanding basic research institutions to leading European biotech SMEs, and has the capability to produce at least 500 humanised mice. HUMAN will generate iPSCs biobanks and comprehensively manage all associated information. HUMAN is uniquely situated to ...
Read Project
17
Partners Participants
FINISHED
Mechanisms underlying hepatocellular carcinoma pathogenesis and impact of co-morbidities. (HEP-CAR)
Start date: Jan 1, 2016, End date: Dec 31, 2019,
...n different co-morbidities and treatment responses. The research and clinical excellence will be combined with the knowledge transfer and communication competence of leading organizations such as the European Association for the Study of the Liver (EASL) and the European Liver Patients Association (ELPA). Thus, HEP-CAR will generate tangible and sustained improvements in the understanding, prevent ...
Read Project
9
Partners Participants
FINISHED
SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS (LIVERHOPE)
Start date: Jan 1, 2017, End date: Dec 31, 2021,
Liver cirrhosis is a very common chronic disease and one of the leading causes of death in European. Moreover, cirrhosis has a marked impact in patients quality of life and represents a major burden for health systems. Treatment of cirrhosis is currently based on symptomatic management of complications and has not changed substantially in the last 20 years. There is an unmet need for therapies tha ...
Read Project
